Lirimilast
CAS: 329306-27-6
Ref. 3D-ENA30627
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
Lirimilast is a biodegradable drug that can be used to treat cancer, cavities, and other diseases. It is also used in clinical trials for the treatment of asthma. Lirimilast has a chemokine-like activity that stimulates the secretion of epidermal growth factor (EGF) and other growth factors. These growth factors promote cell proliferation and inhibit apoptosis. Lirimilast also has an antimuscarinic effect on adrenergic receptors, which may decrease bronchial spasms by blocking acetylcholine release from sympathetic nerves. This drug also has an adrenergic receptor agonist effect that increases the production of inflammatory cells such as leukocytes, neutrophils, monocytes, and macrophages. Lirimilast is degradable and epidermal growth factor-like functional groups are present on its structure.
Chemical properties
Technical inquiry about: 3D-ENA30627 Lirimilast
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
